A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 - PubMed (original) (raw)
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1
T Haruta et al. Mol Endocrinol. 2000 Jun.
Abstract
Insulin receptor substrate-1 (IRS-1) is a major substrate of the insulin receptor and acts as a docking protein for Src homology 2 domain containing signaling molecules that mediate many of the pleiotropic actions of insulin. Insulin stimulation elicits serine/threonine phosphorylation of IRS-1, which produces a mobility shift on SDS-PAGE, followed by degradation of IRS-1 after prolonged stimulation. We investigated the molecular mechanisms and the functional consequences of these phenomena in 3T3-L1 adipocytes. PI 3-kinase inhibitors or rapamycin, but not the MEK inhibitor, blocked both the insulin-induced electrophoretic mobility shift and degradation of IRS-1. Adenovirus-mediated expression of a membrane-targeted form of the p110 subunit of phosphatidylinositol (PI) 3-kinase (p110CAAX) induced a mobility shift and degradation of IRS-1, both of which were inhibited by rapamycin. Lactacystin, a specific proteasome inhibitor, inhibited insulin-induced degradation of IRS-1 without any effect on its electrophoretic mobility. Inhibition of the mobility shift did not significantly affect tyrosine phosphorylation of IRS-1 or downstream insulin signaling. In contrast, blockade of IRS-1 degradation resulted in sustained activation of Akt, p70 S6 kinase, and mitogen-activated protein (MAP) kinase during prolonged insulin treatment. These results indicate that insulin-induced serine/threonine phosphorylation and degradation of IRS-1 are mediated by a rapamycin-sensitive pathway, which is downstream of PI 3-kinase and independent of ras/MAP kinase. The pathway leads to degradation of IRS-1 by the proteasome, which plays a major role in down-regulation of certain insulin actions during prolonged stimulation.
Similar articles
- Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A, Usui I, Haruta T, Kawahara J, Uno T, Iwata M, Kobayashi M. Takano A, et al. Mol Cell Biol. 2001 Aug;21(15):5050-62. doi: 10.1128/MCB.21.15.5050-5062.2001. Mol Cell Biol. 2001. PMID: 11438661 Free PMC article. - Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.
Egawa K, Nakashima N, Sharma PM, Maegawa H, Nagai Y, Kashiwagi A, Kikkawa R, Olefsky JM. Egawa K, et al. Endocrinology. 2000 Jun;141(6):1930-5. doi: 10.1210/endo.141.6.7516. Endocrinology. 2000. PMID: 10830273 - Proteasome inhibitors regulate tyrosine phosphorylation of IRS-1 and insulin signaling in adipocytes.
Rondinone CM, Kramer D. Rondinone CM, et al. Biochem Biophys Res Commun. 2002 Sep 6;296(5):1257-63. doi: 10.1016/s0006-291x(02)02083-1. Biochem Biophys Res Commun. 2002. PMID: 12207909 - [The expression of the insulin receptor substrate-1 (IRS-1) and analysis of its mechanism].
Shichiri M, Araki E. Shichiri M, et al. Nihon Naibunpi Gakkai Zasshi. 1995 Jan 20;71(1):21-6. doi: 10.1507/endocrine1927.71.1_21. Nihon Naibunpi Gakkai Zasshi. 1995. PMID: 7895862 Review. Japanese. - Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.
Gingras S, Côté S, Simard J. Gingras S, et al. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):213-25. doi: 10.1016/s0960-0760(00)00148-5. J Steroid Biochem Mol Biol. 2001. PMID: 11384880 Review.
Cited by
- Targeting integrin α5β1 in urological tumors: opportunities and challenges.
Zhou X, Zhu H, Luo C, Xiao H, Zou X, Zou J, Zhang G. Zhou X, et al. Front Oncol. 2023 Jul 6;13:1165073. doi: 10.3389/fonc.2023.1165073. eCollection 2023. Front Oncol. 2023. PMID: 37483505 Free PMC article. Review. - Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
Smith AE, Chan S, Wang Z, McCloskey A, Reilly Q, Wang JZ, Patel HV, Koshizuka K, Soifer HS, Kessler L, Dayoub A, Villaflor V, Adkins DR, Bruce JY, Ho AL, Perez CA, Hanna GJ, Gascó Hernández A, Saunders A, Dale S, Gutkind JS, Burrows F, Malik S. Smith AE, et al. Cancer Res. 2023 Oct 2;83(19):3252-3263. doi: 10.1158/0008-5472.CAN-23-0282. Cancer Res. 2023. PMID: 37339176 Free PMC article. - Catechins and Proanthocyanidins Involvement in Metabolic Syndrome.
Patanè GT, Putaggio S, Tellone E, Barreca D, Ficarra S, Maffei C, Calderaro A, Laganà G. Patanè GT, et al. Int J Mol Sci. 2023 May 25;24(11):9228. doi: 10.3390/ijms24119228. Int J Mol Sci. 2023. PMID: 37298181 Free PMC article. Review. - Human cytomegalovirus attenuates AKT activity by destabilizing insulin receptor substrate proteins.
Domma AJ, Goodrum FD, Moorman NJ, Kamil JP. Domma AJ, et al. bioRxiv [Preprint]. 2023 Apr 17:2023.04.17.537203. doi: 10.1101/2023.04.17.537203. bioRxiv. 2023. PMID: 37131605 Free PMC article. Updated. Preprint. - Nutrigenomic Effects of White Rice and Brown Rice on the Pathogenesis of Metabolic Disorders in a Fruit Fly Model.
Saka SO, Salisu YY, Sahabi HM, Sanusi KO, Ibrahim KG, Abubakar MB, Isa SA, Liman MG, Shehu S, Malami I, Chan KW, Azmi NH, Imam MU. Saka SO, et al. Molecules. 2023 Jan 5;28(2):532. doi: 10.3390/molecules28020532. Molecules. 2023. PMID: 36677591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous